RxDoctor Payments Data

Robert Sage, DPM

Podiatrist · Beloit, WINPI 1871523316

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,471 of the $4,109 with a category attached, or 84.5%. 22 manufacturers reported payments, led by Organogenesis Inc. at 29.3% of the total. 2025 is the largest year on record at $1,147, 3.0 times the $382 reported in 2019.

$4,109in general payments, 2019–2025

Across 107 payments — averaging $38.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$1K
  • Smith+Nephew$1K
  • Arthrex$477
  • Treace Medical Concepts, Inc.$413
  • Integra Lifesciences Corporation$243
  • Solventum Corporation$118
  • plus $635 from 16 others

What the payments were for

  • Travel & lodging$52113%
  • Food & beverage$3,47184%
  • Education$1173%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,109 in reported general payments places this provider in the 75th percentile of 140 podiatrist providers in Wisconsin.

See all podiatrist providers in Wisconsin

Medicare billing

Part B allowed, 2024
$82,502
Medicare patients
427
Services billed
1,676

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin141$3,007
Diclofenac Sodium74$966
Terbinafine Hcl54$919
Nitroglycerin PatchNitroglycerin19$647
Pregabalin12$526
Ciclopirox11$453
Ropinirole Hcl12$428
Ammonium Lactate24$319
Methylprednisolone52$253
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav25$222
Celecoxib12$198
Cefdinir17$180
Allopurinol24$172
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen31$147
Triamcinolone Acetonide20$113

Paid to pharmacies, not to this prescriber.

Other podiatrist in Beloit

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →